Article

Metformin and Severe Post-COVID-19 Outcomes Among Individuals with Diabetes Mellitus

2026-07-09

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Metformin is one of the most commonly prescribed medications for individuals with diabetes and may provide protection against long-term sequelae of COVID-19. <h4>Methods</h4> We evaluated a retrospective cohort of individuals in the National Clinical Cohort Collaborative with type 2 diabetes mellitus and COVID-19 who were prescribed metformin or a dipeptidyl peptidase-4 inh...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0a0a081b-967b-52a7-87bd-8f457e36800f
DOI: 10.64898/2026.07.06.26357398

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metformin and Severe Post-COVID-19 Outcomes Among Individuals with Diabetes MellitusDOI 10.64898/2026.07.06.26357398Read

GLP Medications and Severe Post-COVID-19 Outcomes Among Individuals with Type 2 Diabetes MellitusSemantic proximity Read

Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.Semantic proximity Read

Risk Phenotypes of Diabetes and Association with COVID-19 Severity and Death – A Living Systematic Review and Meta-AnalysisSemantic proximity Read

Association of COVID-19 with Diabetes: A Systematic Review and Meta-AnalysisSemantic proximity Read

Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.Semantic proximity Read

Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes.Semantic proximity Read

Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 TrialSemantic proximity Read

Metformin at the time of Covid-19 infection and risk of Long Covid: A Target Trial Emulation StudySemantic proximity Read

Type 1 and Type 2 Diabetes and COVID-19 Related Mortality in England: A Whole Population StudySemantic proximity Read

Impact of COVID-19 on diagnoses, monitoring and mortality in people with type 2 diabetes: a UK-wide cohort study involving 14 million people in primary careSemantic proximity Read

Multi-site analysis of COVID-19 and new-onset diabetes reveals need for improved sensitivity of EHR-based COVID-19 phenotypes-a DiCAYA Network analysis.Semantic proximity Read

Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical TrialSemantic proximity Read